|
|
Gene Vaccines
) n4 M7 |. R( g5 {8 }Thalhamer, Josef; Weiss, Richard; Scheiblhofer, Sandra (Eds.): p( ?8 V+ K. A# I ~
1st Edition., 2012, XI, 330 p. 49 illus., 41 in color.# Z3 g4 C, w0 k- a
( w/ s% ?/ \- J bHardcover, ISBN 978-3-7091-0438-58 n+ ~5 H/ l$ B& Z/ J7 a6 N
Online orders shipping within 2-3 days6 x! r( w. ]. Y# X" U7 ~- b
149,95 ) P) f& w1 H- {4 K& ~- H; u
, h* G l4 C1 A目录
$ T- y6 l5 a4 ^0 F' V8 rPreface.- 1 General mechanisms of gene vaccines.- 2 Strategies to Improve DNA Vaccine Potency: HPV-associated Cervical Cancer as a Model System.- 3 Immune-activating mechanisms of replicase-based DNA and RNA vaccines and their role in immune-apoptosis.- 4 Cytokine genes as molecular adjuvants for DNA vaccines.- 5 Pharmaceutical non-viral formulations for gene vaccines.- 6 Rational design of formulated DNA vaccines: the DermaVir approach.- 7 In vivo electroporation.- 8 Electroporation-based Trigrid™ delivery system (TDS) for DNA vaccine administration.- 9 Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines.- 10 Intranodal genetic immunization.- 11 Immunotherapy of cancer with RNA vaccines.- 12 DNA and RNA vaccines for prophylactic and therapeutic treatment of type I allergy.- 13 Approved veterinary vaccines – paving the way to products for human use.- 14 Current status of regulations for DNA vaccines.- 15 State of the art production of antibiotic resistance-free plasmid DNA.- 16 Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy.
& e2 c2 A6 n5 O9 f7 W
) ^8 D7 S4 ?$ ~6 T& `2 b8 [6 f下载地址:# }6 a" C1 Y8 [; o/ M0 i
0 b7 j! M" X- k I
2 ~6 Y% d! J: \1 F& ]/ J- E
|
|